Latest news
Bronstein, Gewirtz & Grossman, LLC Is Investigating Instil Bio, Inc. (TIL) And Encourages Investors to Connect - The National Law ReviewThe National Law Review · Fri, 07 Aug 2026 18:56:24 GMTInstil Bio Inc (TIL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Wed, 05 Aug 2026 07:00:00 GMTInstil Bio Q1 2026 Earnings: EPS Miss Reflects Continued Pre-Clinical-Stage Investment - Investor Earnings Call - dars.gov.etdars.gov.et · Sat, 01 Aug 2026 07:00:00 GMTInstil Bio Inc (TIL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMTInstil Bio Inc (TIL) Financial Health: Profitability & Balance Sheet Analysis - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMTTIL Q2'26 Earnings: revenue estimate is 0 USD - TradingViewTradingView · Fri, 31 Jul 2026 07:00:00 GMTTIL|Instil Bio Inc|Price:7.100|Chg%:-0.020 - TradingKeyTradingKey · Mon, 27 Jul 2026 13:55:18 GMTInstil Bio Inc (TIL) Balance Sheet - TradingKeyTradingKey · Mon, 27 Jul 2026 13:13:29 GMT